| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Mojgan Atashi, Cristian D Gutierrez Reyes, Vishal Sandilya, Waziha Purba, Parisa Ahmadi, Md Abdul Hakim, Firas Kobeissy, Giuseppe Plazzi, Monica Moresco, Bartolo Lanuzza, Raffaele Ferri, Yehia Mechre. LC-MS/MS Quantitation of HILIC-Enriched Biomolecules. vol 13. issue 11. 2023-11-25. PMID:38002271. |
here, we investigate glycoproteins in narcolepsy type 1 (nt1) disease, a form of narcolepsy characterized by cataplexy-the sudden onset of muscle paralysis that is typically triggered by intense emotions. |
2023-11-25 |
2023-11-28 |
human |
| Mélanie Strauss, Lucie Griffon, Maxime Elbaz, Isabelle Arnulf, Mounir Chennaoui, Damien Lége. Altered reinforcement learning in Narcolepsy type I and other central disorders of hypersomnolence. Sleep medicine. vol 113. 2023-11-23. PMID:37995471. |
cognitive impairments are described in central disorders of hypersomnolence (cdh), but studies remain very limited and largely focused on narcolepsy type 1 (nt1). |
2023-11-23 |
2023-11-29 |
human |
| Mélanie Strauss, Lucie Griffon, Maxime Elbaz, Isabelle Arnulf, Mounir Chennaoui, Damien Lége. Altered reinforcement learning in Narcolepsy type I and other central disorders of hypersomnolence. Sleep medicine. vol 113. 2023-11-23. PMID:37995471. |
participants with nt1 (n = 27), other cdh (n = 34, including narcolepsy type 2 and idiopathic hypersomnia, matched with nt1 participants for sleepiness severity), and healthy participants (n = 34) took part in the study. |
2023-11-23 |
2023-11-29 |
human |
| Yuri Mizuno, Taira Uehara, Yuri Nakamura, Toshiki Okadome, Takahiko Mukaino, Kishin Koh, Yoshihisa Takiyama, Takashi Kanbayashi, Noriko Isobe, Jun-Ichi Kira, Hiroyuki Murai, Hiroshi Shiget. A case of monozygotic twins with hereditary spastic paraplegia type 4 and epilepsy, of whom only one developed narcolepsy type 1. Journal of sleep research. 2023-11-20. PMID:37984842. |
we report a case of monozygotic twin sisters with hereditary spastic paraplegia type 4 (spg4) and epilepsy, only one of whom had a diagnosis of narcolepsy type 1 (nt1). |
2023-11-20 |
2023-11-29 |
Not clear |
| Elena S Wenz, Mink S Schinkelshoek, Ulf Kallweit, Rolf Fronczek, Rana Rezaei, Ramin Khatami, Gert Jan Lammers, Claudio L A Bassett. Narcolepsy type 1 and Sydenham chorea - Report of 3 cases and review of the literature. Sleep medicine. vol 112. 2023-11-05. PMID:37925849. |
narcolepsy type 1 (nt1) is an immune-mediated disorder characterized by excessive daytime sleepiness, cataplexy, low levels of hypocretin-1 in the cerebrospinal fluid, and a strong association with the hla dqb1*06:02 allele. |
2023-11-05 |
2023-11-08 |
Not clear |
| Giorgia Simoncini Malucelli, Anna Mercante, Fabio Pizza, Valerio Brunetti, Francesco Biscarini, Stefano Vandi, Alice Mazzoni, Christian Franceschini, Giacomo Della Marca, Catello Vollono, Daniela Pia Rosaria Chieffo, Giuseppe Plazz. Exploring the emotional and behavioural profile in paediatric narcolepsy type 1: A case-control study. Journal of sleep research. 2023-10-24. PMID:37872846. |
narcolepsy type 1 (nt1) is a central disorder of hypersomnolence often arising in childhood and adolescence. |
2023-10-24 |
2023-11-08 |
Not clear |
| Lin Xu, Rong Xue, Zhu Ai, Yaqin Huang, Xuan Liu, Linlin Wang, Danqi Liang, Zuojun Wan. Resting-State Functional Magnetic Resonance Imaging as an Indicator of Neuropsychological Changes in Type 1 Narcolepsy. Academic radiology. 2023-10-11. PMID:37821344. |
to explore indicators of neuropsychological changes in patients with type 1 narcolepsy (nt1) using resting-state functional magnetic resonance imaging (rs-fmri). |
2023-10-11 |
2023-10-15 |
Not clear |
| Mariana Fernandes, Matteo Spanetta, Fabio Placidi, Francesca Izzi, Francesco Negri, Marzia Nuccetelli, Sergio Bernardini, Nicola Biagio Mercuri, Claudio Liguor. A preliminary study investigating the clinical potential of measuring cerebrospinal-fluid lactate levels in patients with narcolepsy type 1 and 2. Physiology & behavior. 2023-10-06. PMID:37802459. |
since csf lactate concentrations fluctuate according to the sleep-wake cycle with higher levels during wakefulness and lower levels during sleep, as documented in animal model studies, the present study aimed at quantifying the csf lactate levels in patients with narcolepsy type 1 (nt1) and 2 (nt2), two sleep disorders featured by excessive daytime sleepiness (eds). |
2023-10-06 |
2023-10-15 |
Not clear |
| Qingqing Zhan, Lili Wang, Nan Liu, Yuqing Yuan, Liying Deng, Yongmin Ding, Fen Wang, Jian Zhou, Liang Xi. Serum metabolomics study of narcolepsy type 1 based on ultra-performance liquid chromatography-tandem mass spectrometry. Amino acids. 2023-09-09. PMID:37689600. |
furthermore, narcolepsy type 1 (nt1) has serious negative impacts on an individual's health, society, and the economy. |
2023-09-09 |
2023-10-07 |
Not clear |
| Marco Menchetti, Francesco Biscarini, Giombattista Sallemi, Elena Antelmi, Christian Franceschini, Stefano Vandi, Giulia Neccia, Valentina Baldini, Giuseppe Plazzi, Fabio Pizz. Phenomenology and psychiatric correlates of pseudocataplexy. Sleep. 2023-09-08. PMID:37682005. |
pseudocataplexy is a rare functional neurological disorder that mimics cataplexy, pathognomonic for narcolepsy type 1 (nt1). |
2023-09-08 |
2023-10-07 |
Not clear |
| L Barateau, F Pizza, S Chenini, L Peter-Derex, Y Dauvillier. Narcolepsies, update in 2023. Revue neurologique. 2023-08-27. PMID:37634997. |
narcolepsy type 1 (nt1) and type 2 (nt2), also known as narcolepsy with and without cataplexy, are sleep disorders that benefited from major scientific advances over the last two decades. |
2023-08-27 |
2023-09-07 |
Not clear |
| Eva Wiberg Torstensen, Niels Christian Haubjerg Østerby, Birgitte Rahbek Kornum, Benedikte Wanscher, Emmanuel Mignot, Mads Barløse, Poul Jørgen Jennu. Repeated polysomnography and multiple sleep latency test in narcolepsy type 1 and other hypersomnolence disorders. Sleep medicine. vol 110. 2023-08-06. PMID:37544279. |
psg and the mslt are moderately reliable at diagnosing narcolepsy type 1 (nt1) but unreliable for diagnosing narcolepsy type 2 (nt2). |
2023-08-06 |
2023-08-14 |
Not clear |
| Chenyang Li, Karen Spruyt, Liang Xie, Chi Zhang, Zhifei Xu, Fang Ha. Development and validation of the narcolepsy severity scale in school aged children. Sleep medicine. vol 110. 2023-07-30. PMID:37517284. |
to develop and psychometrically test the pediatric narcolepsy severity scale (p-nss) for pediatric with narcolepsy type 1 (nt1). |
2023-07-30 |
2023-08-14 |
Not clear |
| Ling Shan, Suzan Linssen, Zoe Harteman, Fleur den Dekker, Lamis Shuker, Rawien Balesar, Nicole Breesuwsma, Jasper Anink, Jingru Zhou, Gert Jan Lammers, Dick F Swaab, Rolf Froncze. Activated wake systems in narcolepsy type 1. Annals of neurology. 2023-07-03. PMID:37395722. |
narcolepsy type 1 (nt1) is assumed to be caused solely by a lack of hypocretin (orexin) neurotransmission. |
2023-07-03 |
2023-08-14 |
Not clear |
| Sara Casale, Valentina Assirelli, Fabio Pizza, Antonio Balsamo, Monia Gennari, Andrea Pession, Giuseppe Plazzi, Alessandra Cassi. Auxological and endocrine findings in narcolepsy type 1: seventeen-year follow-up from a pediatric endocrinology center. Frontiers in endocrinology. vol 14. 2023-07-03. PMID:37396177. |
narcolepsy type 1 (nt1) is a rare hypersomnia of central origin linked to hypocretin deficiency, most frequently arising at pediatric age. |
2023-07-03 |
2023-08-14 |
Not clear |
| Roland S Liblau, Daniela Latorre, Birgitte R Kornum, Yves Dauvilliers, Emmanuel J Migno. The immunopathogenesis of narcolepsy type 1. Nature reviews. Immunology. 2023-07-03. PMID:37400646. |
narcolepsy type 1 (nt1) is a chronic sleep disorder resulting from the loss of a small population of hypothalamic neurons that produce wake-promoting hypocretin (hcrt; also known as orexin) peptides. |
2023-07-03 |
2023-08-14 |
Not clear |
| Kugui Yoshida-Tanaka, Mihoko Shimada, Yoshiko Honda, Akihiro Fujimoto, Katsushi Tokunaga, Makoto Honda, Taku Miyagaw. Narcolepsy type I-associated DNA methylation and gene expression changes in the human leukocyte antigen region. Scientific reports. vol 13. issue 1. 2023-06-28. PMID:37380713. |
narcolepsy type 1 (nt1) is caused by a loss of hypothalamic orexin-producing cells, and autoreactive cd4 |
2023-06-28 |
2023-08-14 |
human |
| Wei-Chih Chin, Yu-Shu Huang, I Tang, Pin-Yi Lee, Chih-Huan Wang, Kuo-Yu Cha. Impact of Taiwan's 2021 COVID-19 lockdown on the symptom severity and quality of life of patients with narcolepsy. Sleep and biological rhythms. 2023-06-26. PMID:37363640. |
patients with type 1 and type 2 narcolepsy (nt1 and nt2, respectively) aged 6-40 years were retrospectively recruited from our narcolepsy cohort study. |
2023-06-26 |
2023-08-14 |
Not clear |
| Yves Dauvilliers, Thomas Roth, Richard Bogan, Michael J Thorpy, Anne Marie Morse, Asim Roy, Jordan Dubow, Jennifer Gudema. Efficacy of Once-Nightly Sodium Oxybate (FT218) in Narcolepsy Type 1 and Type 2: Post Hoc Analysis From the Phase 3 REST-ON Trial. Sleep. 2023-05-29. PMID:37246913. |
post hoc analyses from the phase 3 rest-on trial evaluated efficacy of extended-release once-nightly sodium oxybate (on-sxb; ft218) vs placebo for daytime sleepiness and disrupted nighttime sleep in narcolepsy type 1 (nt1) and 2 (nt2). |
2023-05-29 |
2023-08-14 |
Not clear |
| Samantha Mombelli, François Ricordeau, Léa Gillard, Rosa Lecca, Tiphaine Vidal, Bruno Pereira, Patricia Beudin, Nicolas Vitello, Helene Bastuji, Laure Peter-Derex, Maria Livia Fantin. Psychobehavioural profile in narcolepsy type 1 with and without REM sleep behaviour disorder. Journal of sleep research. 2023-05-24. PMID:37222001. |
rem sleep behaviour disorder (rbd) is common in narcolepsy type 1 (nt1). |
2023-05-24 |
2023-08-14 |
Not clear |